Life Expectancy Increased, But COVID-19 Threatens Gains 13/05/2020 Grace Ren Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading -> Breakthrough Microbe Can Prevent Mosquitoes From Infection By Malaria Parasites 06/05/2020 Gauri Saxena A newly identified microbe, named Microsporidia MB, can prevent mosquitoes from being infected by malaria parasites. This microbe could be used to block the transmission of malaria parasites from mosquito vectors to humans, according to new research published by researchers from the International Centre of Insect Physiology and Ecology (icipe) in Kenya and the University […] Continue reading -> COVID-19 Lockdowns Could Lead to 1.4 Million More Tuberculosis Deaths – But The Solution Is ‘Not Rocket Science’ 06/05/2020 Svĕt Lustig Vijay A 3-month long lockdown could lead to an additional 1.4 million TB deaths and an additional 6.3 million cases over the next five years – if existing tuberculosis services are put on a prolonged hold, reports a new study by the Stop TB Partnership, which estimated the global impact of COVID-19 lockdowns on TB. The […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Breakthrough Microbe Can Prevent Mosquitoes From Infection By Malaria Parasites 06/05/2020 Gauri Saxena A newly identified microbe, named Microsporidia MB, can prevent mosquitoes from being infected by malaria parasites. This microbe could be used to block the transmission of malaria parasites from mosquito vectors to humans, according to new research published by researchers from the International Centre of Insect Physiology and Ecology (icipe) in Kenya and the University […] Continue reading -> COVID-19 Lockdowns Could Lead to 1.4 Million More Tuberculosis Deaths – But The Solution Is ‘Not Rocket Science’ 06/05/2020 Svĕt Lustig Vijay A 3-month long lockdown could lead to an additional 1.4 million TB deaths and an additional 6.3 million cases over the next five years – if existing tuberculosis services are put on a prolonged hold, reports a new study by the Stop TB Partnership, which estimated the global impact of COVID-19 lockdowns on TB. The […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Lockdowns Could Lead to 1.4 Million More Tuberculosis Deaths – But The Solution Is ‘Not Rocket Science’ 06/05/2020 Svĕt Lustig Vijay A 3-month long lockdown could lead to an additional 1.4 million TB deaths and an additional 6.3 million cases over the next five years – if existing tuberculosis services are put on a prolonged hold, reports a new study by the Stop TB Partnership, which estimated the global impact of COVID-19 lockdowns on TB. The […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Combined Impact Of COVID-19 And Malaria Could Be ‘Catastrophic’, Warns Leading Research Group 24/04/2020 Elaine Ruth Fletcher The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch, came in the wake of […] Continue reading -> Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Greets World Chagas Disease Day With New Analysis, New Plans 14/04/2020 Press release [Unitaid] Geneva, Switzerland (14 April 2020) – Unitaid marked the first World Chagas Disease Day with the release of a comprehensive report on how to better confront the potentially deadly parasitic infection that strikes hardest among Latin America’s poor and marginalized. It was on this date in 1909 that a Brazilian doctor, Carlos Chagas, diagnosed […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Collaboration Aims To Fill The Data Gap On Use Of Antimalarials In Pregnancy 09/03/2020 Press release [Medicines for Malaria Venture] Geneva and Liverpool (8 March 2020) – A new collaboration announced on International Women’s Day 2020 aims to help establish pregnancy registries in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarials in one of the most vulnerable populations to malaria. The study, led by […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> Posts navigation Older postsNewer posts